Antibiotics Linked with Increased Arrhythmia, Death Risks

Aimee Simone, Assistant Editor
Published Online: Tuesday, April 1, 2014
Follow Pharmacy_Times:
New study finds that use of azithromycin and levofloxacin are associated with significantly increased risk of death and serious arrhythmia, backing up a safety warning issued by the FDA in March 2013.

Short-term treatment with the antibiotics azithromycin and levofloxacin may increase the risk of serious cardiac arrhythmias and death, the results of a new study indicate.
 
Previous research has shown a relationship between treatment with azithromycin and an increased risk of cardiovascular death and all-cause mortality in Medicaid patients, especially those at a high risk for cardiovascular disease. These findings led the FDA to issue a public safety warning about the potential risks associated with the antibiotic and similar risks linked with levofloxacin.
 
Expanding on this research, the current study, published in the March/April 2014 issue of the Annals of Family Medicine, analyzed data from a cohort of veterans treated with azithromycin, levofloxacin, or amoxicillin and evaluated the risks of cardiac arrhythmia and death associated with use of each antibiotic. The analysis included 14 million patients who were treated at 140 Department of Veterans Affairs Medical Centers and 600 outpatient clinics from September 1999 through April 2012. Azithromycin was typically dispensed for 5 days, while amoxicillin and levofloxacin were generally dispensed for 10 days.  
 
The results indicated that treatment with either azithromycin or levofloxacin was associated with a significant increase in the risk of death and serious arrhythmia. Based on weighted analysis, 228 patients treated with azithromycin and 384 of those treated with levofloxacin per million antibiotics dispensed died after 5 days of treatment, compared with just 154 deaths in patients treated with amoxicillin. At 10 days after the start of treatment, 422 azithromycin patients and 714 levofloxacin patients died per million antibiotics dispensed, compared with 324 amoxicillin patients.
 
Within the first 5 days of treatment, patients receiving azithromycin had a 48% increased risk of death and a 77% increased risk of serious arrhythmia compared with patients who took amoxicillin. During days 6 to 10 after the beginning of treatment, however, the risk of both death and serious arrhythmia in patients receiving azithromycin were not significantly increased compared with those taking amoxicillin.
 
During the first 5 days of treatment, patients who received levofloxacin had a 149% increased risk of death and a 143% increased risk of serious arrhythmia compared with those who took amoxicillin. The increased risks associated with taking levofloxacin compared with taking amoxicillin remained significantly increased throughout the 10-day treatment period, with the risk of death increased 95% and the risk of serious arrhythmia increased 75%.
 
The findings support safety announcements from the manufacturer of azithromycin and the FDA, the authors note. They suggest that providers should consider the risks and benefits of the antibiotics before making prescribing decisions.
 
“There are usually multiple antibiotic choices available for older patients, especially those with cardiac comorbidities; physicians may consider prescribing medications other than azithromycin and levofloxacin,” they conclude.

Related Articles
Reducing elevated blood pressure during pregnancy is safe for the expectant mother and her child.
A pharmacist in Bessemer, Alabama, has been indicted for Medicaid fraud after allegedly scheming with the mother of a terminally ill child, according to Georgia Attorney General Luther Strange’s office.
A primary goal of managing atrial fibrillation is relief of symptoms that include dizziness, fatigue, palpitations, shortness of breath, and chest pain. Yet, it is symptomless in up to one-third of patients.
Women diagnosed with polycystic ovary syndrome are more likely to develop heart disease, diabetes, and other chronic conditions than those without the hormone disorder.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$